                         SEQUENCE LISTING

<110>  Northwestern University
 
<120>  STRUCTURE-FUNCTION RELATIONSHIPS IN THE DEVELOPMENT OF 
       IMMUNOTHERAPEUTIC AGENTS

<130>  30938/2017-215/PC

<150>  US 62/599,395
<151>  2017-12-15

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Cys Ser Ile Ile Asn Phe Glu Lys Leu 
1               5                   


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Cys Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10  


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  3

Val Tyr Asp Phe Ala Phe Arg Asp Leu Cys 
1               5                   10  


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  (Sp18)2 Cholesterol

<400>  4
tccatgacgt tcctgacgtt                                                   20


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  (Sp18)2

<400>  5
tccatgacgt tcctgacgtt tt                                                22


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  Cy5- (Sp18)2-Cholesterol

<400>  6
tccatgacgt tcctgacgtt                                                   20


<210>  7
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  (Sp18)2

<400>  7
tccatgacgt tcctgacgtt tt                                                22


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (20)..(20)
<223>  SH

<400>  8
aacgtcagga acgtcatgga                                                   20


<210>  9
<211>  10
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  SH

<220>
<221>  misc_feature
<222>  (1)..(10)
<223>  Cholesterol

<400>  9
tttttttttt                                                              10


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  10

Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Alpha-NH

<400>  11

Thr Met Arg Ser Ser Ile Ile Asn Phe Glu Lys Leu 
1               5                   10          


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  12

Cys Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10  


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  13

Val Tyr Asp Phe Ala Phe Arg Asp Leu Cys 
1               5                   10  


